Authors:
CAMPION L
GALLOU G
RUELLAND A
CLOAREC L
ALLANNIC H
Citation: L. Campion et al., LIPID AND THYROID CHANGES AFTER PARTIAL THYROIDECTOMY - GUIDELINES FOR L-THYROXINE THERAPY, Clinical chemistry, 41(3), 1995, pp. 473-474
Authors:
GALLOU G
RUELLAND A
CAMPION L
MAUGENDRE D
LEMOULLEC N
LEGRAS B
ALLANNIC H
CLOAREC L
Citation: G. Gallou et al., INCREASE IN THIOBARBITURIC ACID-REACTIVE SUBSTANCES AND VASCULAR COMPLICATIONS IN TYPE-2 DIABETES-MELLITUS, Diabete et metabolisme, 20(3), 1994, pp. 258-264
Authors:
GALLOU G
GUILHEM I
POIRIER JY
RUELLAND A
LEGRAS B
CLOAREC L
Citation: G. Gallou et al., INCREASED SERUM FERRITIN IN INSULIN-DEPENDENT DIABETES-MELLITUS - RELATION TO GLYCEMIC CONTROL, Clinical chemistry, 40(6), 1994, pp. 947-948
Authors:
GALLOU G
RUELLAND A
CAMPION L
ALLANNIC H
LEGRAS B
CLOAREC L
Citation: G. Gallou et al., SUSCEPTIBILITY OF LDL TO LIPID-PEROXIDATI ON IN NON-INSULIN-DEPENDENTDIABETES-MELLITUS WITH AND WITHOUT MACROANGIOPATHY, Annales de biologie clinique, 52(10), 1994, pp. 695-699
Authors:
GALLOU G
LEGRAS B
RUELLAND A
GROSBOIS B
CLOAREC L
Citation: G. Gallou et al., PROBLEMS OF C-REACTIVE PROTEIN DETERMINATION IN PATIENTS WITH MONOCLONAL IMMUNOGLOBULINS, Clinical chemistry, 39(5), 1993, pp. 918-918